ARS Investment Partners, LLC quarter change: Foreign ADRs, Sold out
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), from the quarter ended 2026-03-31 to 2026-06-30, ARS Investment Partners, LLC opened 0 positions, added to 0, reduced 0, sold out of 1 and left 0 unchanged. The largest increase in value was ASCENDIS PHARMA A/S (-$47,908,871); the largest decrease was ASCENDIS PHARMA A/S (-$47,908,871).
- ASCENDIS PHARMA A/S: Country of operation —; Class SPONSORED ADR; Shares 2026-03-31 209,456; Shares 2026-06-30 0.
Two Form 13F-HR filings compared (SEC CIK 733020): 2026-03-31 (filed 2026-04-16) and 2026-06-30 (filed 2026-07-09). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | United States | $1.925B | 77 |
| Clearline Capital LP | United States | $1.925B | 106 |
| INVESTMENT HOUSE LLC | United States | $1.922B | 223 |
| Rehmann Capital Advisory Group | United States | $1.921B | 677 |
| Quinn Opportunity Partners LLC | United States | $1.919B | 360 |
| Hamilton Capital, LLC | United States | $1.930B | 152 |
| Stairway Partners, LLC | United States | $1.930B | 18 |
| AdvisorNet Financial, Inc | United States | $1.932B | 2,267 |
| 683 Capital Management, LLC | United States | $1.916B | 237 |
| Heard Capital LLC | United States | $1.934B | 21 |